Position in CERS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$26,280
+$9,900 QoQ
Shares Held
9,000
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#152
of 183 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Capital Advisors, Ltd. LLC holds $1,138,671 across 21 Medical Devices names. CERS ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,625 | $328,932 | |
| 2 | SYK |
Stryker Corp
|
818 | $257,539 | |
| 3 | MDT |
Medtronic plc
|
2,935 | $229,605 | |
| 4 | EW |
Edwards Lifesciences Corp
|
2,259 | $204,349 | |
| 5 | DXCM |
Dexcom Inc
|
490 | $33,001 | |
| 6 | CERS |
Cerus Corp
This page
|
9,000 | $26,280 | |
| 7 | BSX |
Boston Scientific Corp
|
445 | $18,992 | |
| 8 | STE |
STERIS plc
|
65 | $13,687 |
All Filings in CERS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,280 | 9,000 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $16,380 | 9,000 | Shares | Sole | 2026-04-16 | |
| 2024-12-31 | $1 | 447 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1 | 484 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1 | 484 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $914 | 484 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $1,045 | 484 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $1 | 768 | Shares | Sole | 2023-10-27 | |
| No filing history on record for this holder in this stock. | ||||||